---
title: "《盈喜》正大企業預告首九月溢利倍增至 2,350 萬美元"
description: "正大企業國際發盈喜，預計 9 月止九個月溢利約 2,350 萬美元，相較上年同期錄得 430 萬美元。溢利增長主要因集團成功實施開發大客户銷售的關鍵策略，收入大幅增長。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/262076930.md"
published_at: "2025-10-21T13:32:36.000Z"
---

# 《盈喜》正大企業預告首九月溢利倍增至 2,350 萬美元

> 正大企業國際發盈喜，預計 9 月止九個月溢利約 2,350 萬美元，相較上年同期錄得 430 萬美元。溢利增長主要因集團成功實施開發大客户銷售的關鍵策略，收入大幅增長。

正大企業國際 (03839.HK) 發盈喜，預計 9 月止九個月溢利約 2,350 萬美元，相較上年同期錄得 430 萬美元。溢利增長主要因集團成功實施開發大客户銷售的關鍵策略，收入大幅增長。

### Related Stocks

- [03839.HK - 正大企業國際](https://longbridge.com/zh-HK/quote/03839.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Chia Tai Forecasts Rise in 2025 Profit | Chia Tai Forecasts Rise in 2025 Profit | [Link](https://longbridge.com/zh-HK/news/273363782.md) |
| CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | [Link](https://longbridge.com/zh-HK/news/276051793.md) |
| CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | [Link](https://longbridge.com/zh-HK/news/276035104.md) |
| Lenovo Caught Napping By 'Democratization Of AI' | Lenovo reported a 21% profit decline in its latest fiscal quarter, taking a $285 million restructuring charge due to a s | [Link](https://longbridge.com/zh-HK/news/275904944.md) |
| Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12.04 From HK$9.11, Keeps at Buy | Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12.04 From HK$9.11, Keeps at Buy | [Link](https://longbridge.com/zh-HK/news/276056763.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。